title: Biotargeted nanomedicines for cancer: six tenets before you begin.
abstract: Biotargeted nanomedicines have captured the attention of academic and industrial scientists who have been motivated by the theoretical possibilities of the 'magic bullet' that was first conceptualized by Paul Ehrlich at the beginning of the 20th century. The Biotargeting Working Group, consisting of more than 50 pharmaceutical scientists, engineers, biologists and clinicians, has been formed as part of the National Cancer Institute's Alliance for Nanotechnology in Cancer to harness collective wisdom in order to tackle conceptual and practical challenges in developing biotargeted nanomedicines for cancer. In modern science and medicine, it is impossible for any individual to be an expert in every aspect of biology, chemistry, materials science, pharmaceutics, toxicology, chemical engineering, imaging, physiology, oncology and regulatory affairs. Drawing on the expertise of leaders from each of these disciplines, this commentary highlights six tenets of biotargeted cancer nanomedicines in order to enable the translation of basic science into clinical practice.
authors: Dana-Farber Cancer Institute, Harvard Medical School, Boston, MA 02215, USA.
authors: Michael S
authors: MS
authors: Goldberg
authors: Sara S
authors: SS
authors: Hook
authors: Andrew Z
authors: AZ
authors: Wang
authors: Jeff W M
authors: JW
authors: Bulte
authors: Anil K
authors: AK
authors: Patri
authors: Fatih M
authors: FM
authors: Uckun
authors: Vincent L
authors: VL
authors: Cryns
authors: Justin
authors: J
authors: Hanes
authors: Demir
authors: D
authors: Akin
authors: Jennifer B
authors: JB
authors: Hall
authors: Nastaran
authors: N
authors: Gharkholo
authors: Russell J
authors: RJ
authors: Mumper
mesh_terms: D000818:Animals; D006801:Humans; D050997:Nanomedicine / Q000379:methods*; D009369:Neoplasms
references: Adv Mater. 2011 Mar 25;23(12):H79-83
references: 21433105
references: Small. 2010 Sep 20;6(18):2041-9
references: 20721949
references: Cell. 2011 Mar 4;144(5):646-74
references: 21376230
references: J Vasc Surg. 2005 Jul;42(1):40-6
references: 16012450
references: J Control Release. 2010 Sep 1;146(2):164-74
references: 20385183
references: Mol Pharm. 2012 Mar 5;9(3):382-93
references: 22026635
references: Biomaterials. 2012 Jan;33(2):583-91
references: 22014944
references: Nat Nanotechnol. 2009 Jul;4(7):411-4
references: 19581891
references: Cell. 2011 Jun 10;145(6):926-40
references: 21663795
references: Mol Pharm. 2008 Jul-Aug;5(4):487-95
references: 18510338
references: PLoS One. 2011;6(11):e25507
references: 22087216
references: Proc Natl Acad Sci U S A. 2011 Feb 8;108(6):2426-31
references: 21245339
references: Nano Lett. 2008 Aug;8(8):2180-7
references: 18605701
references: ACS Nano. 2008 Dec 23;2(12):2481-8
references: 19206282
references: Cancer Prev Res (Phila). 2010 Nov;3(11):1361-4
references: 20959519
references: Science. 2011 Jul 29;333(6042):527
references: 21798916
references: ACS Nano. 2011 Aug 23;5(8):6184-94
references: 21728341
references: Methods Mol Biol. 2011;697:17-31
references: 21116951
references: J Control Release. 2011 Jul 15;153(1):16-22
references: 21342659
references: Nature. 2005 Jul 28;436(7050):568-72
references: 16049491
references: Mol Pharm. 2011 Feb 7;8(1):143-52
references: 20977190
references: Adv Drug Deliv Rev. 2009 Jun 21;61(6):428-37
references: 19376175
references: Nat Rev Drug Discov. 2008 Sep;7(9):771-82
references: 18758474
references: Bioconjug Chem. 1995 Jul-Aug;6(4):367-72
references: 7578355
references: Acc Chem Res. 2011 Oct 18;44(10):947-56
references: 21848277
references: Biochim Biophys Acta. 2011 Mar;1810(3):317-29
references: 20493927
references: Nanoscale. 2010 Aug;2(8):1413-6
references: 20820725
references: Cancer Sci. 2011 Jul;102(7):1247-52
references: 21447010
references: J Immunol Methods. 1996 May 10;191(1):1-10
references: 8642195
references: Mol Pharm. 2010 Aug 2;7(4):993-1006
references: 20481608
references: ACS Nano. 2011 Jun 28;5(6):4284-92
references: 21513353
references: J Am Chem Soc. 2011 Oct 19;133(41):16680-8
references: 21910482
references: J Control Release. 2010 Nov 1;147(3):436-43
references: 20727921
references: Proc Natl Acad Sci U S A. 2009 Nov 3;106(44):18437-42
references: 19841273
references: Nat Biotechnol. 2010 Dec;28(12):1267-70
references: 21139609
references: ChemMedChem. 2008 Dec;3(12):1839-43
references: 19012296
references: Drug Metab Dispos. 2008 Aug;36(8):1709-15
references: 18490436
references: Cancer Res. 2006 Jul 1;66(13):6732-40
references: 16818648
references: Small. 2009 Feb;5(2):235-43
references: 19089838
references: Small. 2009 May;5(10):1207-12
references: 19235198
references: Expert Opin Drug Deliv. 2009 Aug;6(8):865-78
references: 19637974
references: Proc Natl Acad Sci U S A. 2010 Jan 19;107(3):981-6
references: 20080556
references: Proc Natl Acad Sci U S A. 2011 Oct 18;108(42):17450-5
references: 21969599
references: Transl Oncol. 2011 Apr 01;4(2):71-82
references: 21461170
references: Mol Pharm. 2008 Jul-Aug;5(4):473
references: 18672948
references: Sci Transl Med. 2012 Apr 4;4(128):128ra39
references: 22491949
references: Methods Mol Biol. 2010;624:385-92
references: 20217610
references: Nat Rev Clin Oncol. 2010 Nov;7(11):653-64
references: 20838415
references: Small. 2011 Jul 18;7(14):1919-31
references: 21695781
references: Endocrinology. 2010 Feb;151(2):458-65
references: 20016026
references: Proc Natl Acad Sci U S A. 2007 Sep 25;104(39):15549-54
references: 17875985
references: Ann Biomed Eng. 2011 Apr;39(4):1235-51
references: 21350890
references: Biomaterials. 2009 Mar;30(8):1657-64
references: 19101031
references: Gastroenterology. 2009 May;136(5):1514-25.e2
references: 19208341
references: ACS Nano. 2012 Jan 24;6(1):227-33
references: 22111891
references: Small. 2008 Sep;4(9):1307-12
references: 18690639
references: Nanomedicine. 2011 Apr;7(2):201-9
references: 20816874